INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "GLUCAGON RECEPTOR AGONISTS, CONJUGATED TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANTIBODIES"

GENEVA, Sept. 10 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/017549) for "GLUCAGON RECEPTOR AGONISTS, CONJUGATED TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANTIBODIES" on Feb 27, 2025. With publication no. WO/2025/184315, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FALSEY, James, R. (c/o Amgen Inc., One Amgen Center DriveLaw Department - Patent Operations M/S 28-5-AThousand Oaks, CA 91320-1799), WU, Bin (c/o Amgen Inc., One Amgen Center DriveLaw Depart...